RE:$1.40 -$1.50 usd targets I'm not really holding my breath on Bezalip, although it will be nice when that revenue comes on stream. They still have to get approved by the FDA and finish that process which will probably take another year, about the same time Bilastine will start selling, so late 2015, early 2016 should be good times for TRX, assuming nothing unforseen happens. While I'd like an announcement like everyone else, I'm content to wait for the next positive earnings report and eventual listing onto the TMX for some greater investor exposure; althought striking a Bezalip deal with big US pharma would put it on the map tomorrow. Just gotta wait and be patient I guess zzzzzzzz.